Medicare Enrolled
Dr. Nathan Peffer, M.D.
Urology Physician · Doylestown, PA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Peffer from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Peffer?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Peffer
Dr. Nathan Peffer is an urology physician in Doylestown, PA, with 11 years of NPI registration. Based on federal Medicare data, Dr. Peffer performed 1,126 Medicare services across 891 unique beneficiaries.
Between the years covered by Open Payments, Dr. Peffer received a total of $5,188 from 41 pharmaceutical and/or device companies across 204 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Peffer is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 11 years in practice
▲ Top 45% volume in PA
$5,188 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,126
Medicare services
Top 45% in PA for urology physician
891
Unique beneficiaries
$75
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~102 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
327 | $98 | $205 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
111 | $3 | $20 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
95 | $8 | $48 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
94 | $67 | $145 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
79 | $112 | $270 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
60 | $41 | $120 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
51 | $65 | $450 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
49 | $65 | $150 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
35 | $136 | $290 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
29 | $16 | $55 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
22 | $86 | $180 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
21 | $107 | $275 |
| Initial hospital admission, low complexity Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter. |
20 | $68 | $200 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
19 | $142 | $300 |
| Ureteral stone crushing with stent insertion An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open. |
16 | $358 | $850 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
16 | $106 | $1,500 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
16 | $25 | $270 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
14 | $7 | $120 |
| Endoscopic removal of foreign body, stone, or stent from urethra or bladder A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item. |
14 | $123 | $700 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
14 | $136 | $800 |
| Non-needle muscle activity measurement of bladder and bowel openings This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles. |
12 | $27 | $300 |
| Abdominal device insertion with pressure and urine flow study A procedure involving the placement of a device into the abdomen, accompanied by a study to measure pressure and urine flow rate. |
12 | $163 | $375 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
3.9% high complexity
11.3% medium
84.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$5,188
Total received (2019-2024)
Avg $865/year across 6 years
Top 27% in PA for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
41
Companies
204
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,078 (97.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$110 (2.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,359
2023
$1,423
2022
$1,010
2021
$1,038
2020
$183
2019
$175
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Medtronic, Inc.
$510
ABBVIE INC.
$211
Teleflex LLC
$81
UROGEN PHARMA, INC.
$79
COLOPLAST CORP
$51
Sumitomo Pharma America, Inc.
$48
PROGENICS PHARMACEUTICALS, INC.
$47
Axonics, Inc.
$44
Myriad Genetic Laboratories, Inc.
$35
Merck Sharp & Dohme LLC
$32
Baxter Healthcare
$30
Laborie Medical Technologies Corp.
$30
Blue Earth Diagnostics Limited
$28
Tolmar, Inc.
$23
Astellas Pharma US Inc
$22
Photocure Inc
$22
Endo USA, Inc.
$22
C. R. Bard, Inc. & Subsidiaries
$16
Mission Pharmacal Company
$15
IMMUNITYBIO, INC.
$14
Top 3 companies account for 59.0% of 2024 payments
All-time payments by company (2019-2024) ›
Medtronic, Inc.
$1,491
Teleflex LLC
$506
Astellas Pharma US Inc
$442
ABBVIE INC.
$353
Bayer Healthcare Pharmaceuticals Inc.
$231
Boston Scientific Corporation
$196
180 Medical, Inc.
$153
Allergan, Inc.
$121
Retrophin, Inc.
$121
Olympus America Inc.
$107
Sumitomo Pharma America, Inc.
$90
Blue Earth Diagnostics Limited
$81
Myovant Sciences Inc.
$79
UROGEN PHARMA, INC.
$79
AbbVie Inc.
$77
Merck Sharp & Dohme LLC
$73
COLOPLAST CORP
$63
BOSTON SCIENTIFIC CORPORATION
$62
Hollister Incorporated
$58
Laborie Medical Technologies Corp.
$51
Mission Pharmacal Company
$49
C. R. Bard, Inc. & Subsidiaries
$49
PFIZER INC.
$49
PROGENICS PHARMACEUTICALS, INC.
$47
DENTSPLY IH AB
$47
Endo Pharmaceuticals Inc.
$45
Axonics, Inc.
$44
Telix Pharmaceuticals
$41
Progenics Pharmaceuticals, Inc.
$41
Photocure Inc
$40
ConvaTec Inc.
$40
PROCEPT BioRobotics Corporation
$39
Tolmar, Inc.
$38
Myriad Genetic Laboratories, Inc.
$35
Baxter Healthcare
$30
Dendreon Pharmaceuticals LLC
$27
Endo USA, Inc.
$22
Trevena, Inc.
$22
TOLMAR Pharmaceuticals, Inc.
$18
AstraZeneca Pharmaceuticals LP
$18
IMMUNITYBIO, INC.
$14
Top 3 companies account for 47.0% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · AMS · AMS 700 CXR RTE KIT · ANKTIVA · AQUABEAM ROBOTIC SYSTEM · Altis · Axonics · Axumin · BOTOX · Bard Urinary Drainage Bag · CYSVIEW · ELIGARD · GEMTESA · GENTLECATH · General - Erectile Dysfunction · General - Kidney Stone Disease · ILLUCCIX · INTERSTIM · Infyna Chic · JATENZO · JELMYTO · KEYTRUDA · LITHOVUE · LUPRON DEPOT · LYNPARZA · LithoVue · LoFric · Luja Coude · MYRBETRIQ · Myrbetriq · Nubeqa · ORGOVYX · Olinvyk · Optilume BPH Drug Coated Balloon Catheter · PERCLOT · POSLUMA · PROLARIS · PROVENGE · PYLARIFY · SpaceOAR VUE System - 10mL · SpeediCath · URIBEL · URIBEL TABS · UROLIFT · Uribel · UroLift System · VaPro Pocket · XIAFLEX · XTANDI · Xtandi · iTIND System · rezum Generator
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
253
Per 100K population
39.2
County median income
$111,951
Nearest hospital
DOYLESTOWN HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Peffer is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Peffer experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Peffer performed 327 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Peffer receive payments from pharmaceutical companies?
Yes. Dr. Peffer received a total of $5,188 from 41 companies across 204 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Peffer's costs compare to other urology physicians in Doylestown?
Dr. Peffer's average Medicare payment per service is $75. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Peffer) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Doylestown
Browse urology physicians in Doylestown ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in PA
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in PA
Which PA urology physicians receive the most from drug and device companies.
By company
Medtronic, Inc. Payments to Doctors
See all physicians who received payments from Medtronic, Inc.
By company
Teleflex LLC Payments to Doctors
See all physicians who received payments from Teleflex LLC.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology